September 25, 2025

Matthew Lerner, PhD, an associate professor and life courses outcomes program leader in the A.J. Drexel Autism Institute at Dornsife School of Public Health, was quoted in a Sept. 24 MIT Technology Review article about whether leucovorin could be a treatment for autism.

Additionally Lerner was quoted along with Brian Lee, PhD, in a Sept. 22 Philadelphia Inquirer article about what the data shows about causes of autism.

Link to story (MIT Technology Review)

Link to story (The Philadelphia Inquirer)

Lerner was also quoted in a Sept. 26 article in The Guardian about the recently FDA-approved generic drug leucovorin and quoted in a Sept. 28 NewsNation segment about ways to empower children with autism.

Link to story (The Guardian)

Link to story (NewsNation-web)

Link to story (NewsNation-broadcast)

Lerner was also quoted in an Oct. 7 WIRED article about online discourse pertaining to leucovorin for those with autism.

Link to story (WIRED)